Transthyretin amyloidosis in aortic stenosis: clinical and therapeutic implications

Gioele Fabbri1, Matteo Serenelli1, Anna Cantone1

  • 1Centro Cardiologico, Università di Ferrara, via Aldo Moro 8, Cona, 44124 Ferrara, Italy.

Insights

About 14% of elderly patients with severe aortic stenosis also have transthyretin amyloid cardiomyopathy. This association may stem from valve infiltration triggering calcification or aortic stenosis-induced strain promoting amyloidosis. Valve replacement is viable for these patients.

Area of Science:

  • Cardiology
  • Geriatrics
  • Biomedical Science

Background:

  • Severe calcific aortic stenosis (AS) frequently coexists with transthyretin amyloid cardiomyopathy (AC-TTR) in elderly individuals.
  • The underlying mechanisms linking AS and AC-TTR are not fully understood but may involve amyloid infiltration triggering valve calcification or AS-induced strain promoting amyloidogenesis.

Purpose of the Study:

  • To explore the association between AS and AC-TTR.
  • To investigate the diagnostic clues for coexisting AC-TTR in AS patients.
  • To evaluate the prognostic implications of AC-TTR in patients undergoing transcatheter aortic valve replacement (TAVR).

Main Methods:

  • Clinical data analysis of elderly patients with severe AS and AC-TTR.
  • Echocardiogram and ECG findings in patients with coexisting AS and AC-TTR.
  • Bone scintigraphy for AC-TTR diagnosis.
  • Prognostic evaluation of TAVR candidates with AS and AC-TTR.

Main Results:

  • Approximately 14% of elderly patients with severe AS also have AC-TTR.
  • Echocardiography, ECG, and carpal tunnel syndrome history can suggest coexisting AC-TTR.
  • Bone scintigraphy confirms AC-TTR diagnosis.
  • AC-TTR does not significantly impact TAVR procedural outcomes but is linked to increased long-term heart failure risk.

Conclusions:

  • AS and AC-TTR commonly coexist in the elderly, with potential shared pathophysiological links.
  • Early suspicion and diagnostic confirmation of AC-TTR are crucial in AS patients.
  • Transcatheter aortic valve replacement remains a valid option for patients with AS and AC-TTR, provided standard clinical indications are met.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
70
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
44
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
72
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
48
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
47
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
78